Voyager Therapeutics (VYGR) Return on Invested Capital (2017 - 2026)

Voyager Therapeutics has disclosed Return on Invested Capital across 6 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.01% for Q1 2026 at Voyager Therapeutics, down from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2023 to a low of 0.01% in Q1 2026.
• The 4-year median for Return on Invested Capital is 0.0% (2024), against an average of 0.0%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2024, while the deepest fall reached 1 bps in 2024.
• Voyager Therapeutics' Return on Invested Capital stood at 0.0% in 2023, then tumbled by 298 bps to 0.0% in 2024, then tumbled by 138 bps to 0.01% in 2025, then slipped by 9 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.